PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
Open Access
- 1 October 2010
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (10), 3443-3454
- https://doi.org/10.1172/jci40905
Abstract
Excess lipid accumulation in the heart is associated with decreased cardiac function in humans and in animal models. The reasons are unclear, but this is generally believed to result from either toxic effects of intracellular lipids or excessive fatty acid oxidation (FAO). PPARγ expression is increased in the hearts of humans with metabolic syndrome, and use of PPARγ agonists is associated with heart failure. Here, mice with dilated cardiomyopathy due to cardiomyocyte PPARγ overexpression were crossed with PPARα-deficient mice. Surprisingly, this cross led to enhanced expression of several PPAR-regulated genes that mediate fatty acid (FA) uptake/oxidation and triacylglycerol (TAG) synthesis. Although FA oxidation and TAG droplet size were increased, heart function was preserved and survival improved. There was no marked decrease in cardiac levels of triglyceride or the potentially toxic lipids diacylglycerol (DAG) and ceramide. However, long-chain FA coenzyme A (LCCoA) levels were increased, and acylcarnitine content was decreased. Activation of PKCα and PKCδ, apoptosis, ROS levels, and evidence of endoplasmic reticulum stress were also reduced. Thus, partitioning of lipid to storage and oxidation can reverse cardiolipotoxicity despite increased DAG and ceramide levels, suggesting a role for other toxic intermediates such as acylcarnitines in the toxic effects of lipid accumulation in the heart.This publication has 91 references indexed in Scilit:
- Rescue of Cardiomyopathy in Peroxisome Proliferator-Activated Receptor-α Transgenic Mice by Deletion of Lipoprotein Lipase Identifies Sources of Cardiac Lipids and Peroxisome Proliferator-Activated Receptor-α ActivatorsCirculation, 2010
- DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates LipotoxicityOnline Journal of Public Health Informatics, 2009
- Protection of C. elegans from Anoxia by HYL-2 Ceramide SynthaseScience, 2009
- Cellular retinol-binding protein type III is a PPARγ target gene and plays a role in lipid metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Cidea is associated with lipid droplets and insulin sensitivity in humansProceedings of the National Academy of Sciences of the United States of America, 2008
- Hepatic Overexpression of Hormone-sensitive Lipase and Adipose Triglyceride Lipase Promotes Fatty Acid Oxidation, Stimulates Direct Release of Free Fatty Acids, and Ameliorates SteatosisJournal of Biological Chemistry, 2008
- Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heartJCI Insight, 2007
- Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistanceProceedings of the National Academy of Sciences of the United States of America, 2007
- Activation of endoplasmic reticulum stress response during the development of ischemic heart diseaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994